Rimrock Gold Stock Price, News & Analysis
Company Description
Rimrock Gold (OTC Link: RMRK) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $865.2K.
RMRK stock has gained 0.0% over the past year. Shares last traded at $0.0003.
This page provides a comprehensive overview of RMRK stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Rimrock Gold (RMRK) stock last traded at $0.0003, up 25.00% from the previous close. At a market capitalization of $865.2K, RMRK is classified as a micro-cap stock with approximately 2.9B shares outstanding.
Latest News
Rimrock Gold has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all RMRK news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Rimrock Gold (RMRK) currently stands at 500.0 thousand shares. Over the past 12 months, short interest has increased by 56.3%.
Days to Cover History
Days to cover for Rimrock Gold (RMRK) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
RMRK Company Profile & Sector Positioning
Rimrock Gold (RMRK) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing RMRK often look at related companies in the same sector, including Adastra Holdings Ltd (XTXXF), Nexien Biopharma (NXEN), Kaya Hldgs Inc (KAYS), Pharmadrug Inc (LMLLF), and Cann American Corp (CNNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RMRK's relative position within its industry.